Results
626
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
626 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
605499 | CN¥243.15 | 0.1% | 94.3% | CN¥126.4b | CN¥262.72 | PE40.9x | E25.1% | 0.8% | Food, Beverage & Tobacco | ||
600760 | CN¥46.56 | -0.7% | 31.4% | CN¥128.3b | CN¥53.90 | PE52.1x | E29.4% | 0.3% | Capital Goods | ||
RHM | €742.40 | 3.4% | 128.6% | €32.2b | €764.07 | PE47.1x | E29.9% | 0.8% | Capital Goods | ||
ARES | US$193.42 | -0.2% | 59.2% | US$60.6b | US$195.00 | PE90.3x | E38.4% | 1.9% | Diversified Financials | ||
ONON | US$63.04 | 7.7% | 137.3% | US$19.9b | US$62.47 | PE145.3x | E29.7% | n/a | Consumer Durables | ||
NVDA | US$123.70 | -16.0% | 96.3% | US$3.0t | US$173.78 | PE48x | E24.5% | 0.03% | Semiconductors | ||
ALNY | US$273.99 | 2.8% | 58.5% | US$36.0b | US$299.74 | PS16.9x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
9992 | HK$94.00 | 6.0% | 419.9% | HK$124.7b | HK$96.02 | PE75.9x | E35.8% | 0.3% | Retail | ||
300308 | CN¥114.82 | -13.0% | 56.4% | CN¥126.8b | CN¥196.50 | PE27.4x | E33.1% | 0.3% | Tech | ||
MRVL | US$106.79 | -14.7% | 57.7% | US$89.9b | US$127.52 | PS17.2x | E69.5% | 0.2% | Semiconductors | ||
NU | US$12.55 | 4.7% | 45.8% | US$60.8b | US$15.06 | PB7.9x | E25.2% | n/a | Banks | ||
511243 | ₹1,279.30 | 2.7% | 11.6% | ₹1.1t | ₹1,509.06 | PE27.9x | E21.5% | 0.2% | Diversified Financials | ||
300502 | CN¥125.77 | -11.1% | 196.6% | CN¥89.1b | CN¥161.36 | PE46.8x | E36.6% | 0.1% | Tech | ||
2345 | NT$763.00 | 0% | 40.8% | NT$426.4b | NT$789.38 | PE43.8x | E25.1% | 1.3% | Tech | ||
A196170 | ₩362,000.00 | 4.3% | 407.0% | ₩19.3t | ₩565,000.00 | PS259.4x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$96.78 | 2.1% | 5.8% | US$18.6b | US$128.18 | PE9.8x | E20.8% | 6.8% | Diversified Financials | ||
600989 | CN¥17.53 | 5.2% | 31.4% | CN¥128.6b | CN¥21.74 | PE20.4x | E38.5% | 1.6% | Materials | ||
ITCI | US$127.02 | -0.1% | 88.6% | US$13.5b | US$127.45 | PS22x | E52.2% | n/a | Pharmaceuticals & Biotech | ||
BAM | CA$88.51 | 7.7% | 63.7% | CA$36.9b | CA$73.97 | PE57.2x | E87.6% | 2.5% | Diversified Financials | ||
SMCI | US$27.80 | -17.9% | -47.5% | US$16.5b | US$40.79 | PE13.5x | E24.3% | n/a | Tech | ||
PME | AU$271.82 | 0.6% | 170.1% | AU$28.1b | AU$215.57 | PE343.1x | E22.5% | 0.2% | Healthcare | ||
SOLARINDS | ₹10,063.70 | 5.3% | 58.7% | ₹865.9b | ₹11,698.00 | PE90.1x | E27.0% | 0.08% | Materials | ||
ISCTR | ₺14.66 | -1.1% | 42.9% | ₺416.6b | ₺18.68 | PB1.3x | E41.0% | 2.0% | Banks | ||
6669 | NT$2,240.00 | 0% | 3.2% | NT$416.3b | NT$3,007.76 | PE21.6x | E24.1% | 1.9% | Tech |